Diabetes Summitt 2013:
Dr. Karen Segal's (Current Senior Vice President, Diabetes and Metabolic Diseases at Mesoblast, Inc) presenting on Tuesday 30th April 13 (b/w 8.00am & 9.45am)
http://www.gtcbio.com/index.php?option=com_conference&file=program&cn=3rd Diabetes Summit&cid=115
Dr. Karen Segal's Overview
Current Senior Vice President, Diabetes and Metabolic Diseases at Mesoblast, Inc.
- Vice President, Diabetes Clinical Development and Metabolic Therapeutics at Mesoblast LTD
- Past Clinical Development at Roche ; Senior Medical Director and Scientific Officer for Metabolism; Medical Affairs at sanofi-aventis
Thanks Khunfoti...much appreciated.
d summit, page-5
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |